Authors
Ian Duncan, Xiyue Liao, Terri Maxwell
Published in
The American journal of hospice & palliative care. Pages 10499091261462816. Jun 29, 2026. Epub Jun 29, 2026.
Abstract
Hospice has become an important component of End-of-life care in the United States. The use of hospice, however, remains subject to many forces, including the patient, providers, families and cultural beliefs. One consequence of these forces is significant variability of survival of patients in hospice. In a recent study, the authors reported a median survival of approximately 24 days after enrollment. However, a significant minority of patients survive for more than 180 days (the target set by CMS for the Medicare hospice benefit). We examine the factors contributing to the variability of hospice patient survival, including demographics, diagnoses, care setting, and patient drug prescriptions. We apply Cox proportional hazards models to assess the effect of covariates on time-to-event (in this case death in hospice). A high hazard ratio is associated with a shorter life expectancy. In addition to these factors we evaluated medication exposure variables. Medications are strongly associated with the mortality hazard: analgesic use is associated with a nearly three-fold higher hazard (HR = 2.977), and anxiolytic use with a roughly two-fold higher hazard (HR = 1.910) when compared with the group without any anxiolytic use. We provide a detailed understanding of medication use near the end of life that serve as an indicator that medication trajectories can serve as an additional indicator of symptom burden and individualized care planning.
PMID:
42372182
Bibliographic data and abstract were imported from PubMed on 30 Jun 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 2
- Comments 0